Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biocept, Inc. stock logo
BIOC
Biocept
$0.97
$0.32
$27.00
$1.14M0.69764,067 shs751,400 shs
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
$17.04
-0.5%
$17.69
$4.66
$34.05
$66.59M1.66134,027 shs477,598 shs
Psychemedics Corporation stock logo
PMD
Psychemedics
$2.67
$2.52
$1.50
$3.25
N/AN/A36,701 shs113,627 shs
United Treatment Centers Inc. stock logo
POTN
United Treatment Centers
$0.00
$0.00
$0.00
N/AN/AN/A1 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biocept, Inc. stock logo
BIOC
Biocept
0.00%0.00%0.00%0.00%0.00%
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
-0.53%+8.74%+5.90%+41.76%+38.88%
Psychemedics Corporation stock logo
PMD
Psychemedics
0.00%0.00%0.00%0.00%+9.88%
United Treatment Centers Inc. stock logo
POTN
United Treatment Centers
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biocept, Inc. stock logo
BIOC
Biocept
N/AN/AN/AN/AN/AN/AN/AN/A
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Psychemedics Corporation stock logo
PMD
Psychemedics
N/AN/AN/AN/AN/AN/AN/AN/A
United Treatment Centers Inc. stock logo
POTN
United Treatment Centers
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biocept, Inc. stock logo
BIOC
Biocept
0.00
N/AN/AN/A
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
0.00
N/AN/AN/A
Psychemedics Corporation stock logo
PMD
Psychemedics
0.00
N/AN/AN/A
United Treatment Centers Inc. stock logo
POTN
United Treatment Centers
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biocept, Inc. stock logo
BIOC
Biocept
$25.86M0.00N/AN/A$15.60 per share0.00
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
$4.46M14.93N/AN/A$6.78 per share2.51
Psychemedics Corporation stock logo
PMD
Psychemedics
$19.68M0.83N/AN/A$0.84 per share3.18
United Treatment Centers Inc. stock logo
POTN
United Treatment Centers
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biocept, Inc. stock logo
BIOC
Biocept
-$32.09M-$58.45N/AN/AN/AN/A-468.87%-118.41%N/A
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
-$41.87M-$20.09N/AN/AN/A-1,393.50%-141.66%-88.74%N/A
Psychemedics Corporation stock logo
PMD
Psychemedics
-$1.86M-$0.51N/AN/A-9.26%-32.32%-18.53%N/A
United Treatment Centers Inc. stock logo
POTN
United Treatment Centers
N/AN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biocept, Inc. stock logo
BIOC
Biocept
N/AN/AN/AN/AN/A
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
N/AN/AN/AN/AN/A
Psychemedics Corporation stock logo
PMD
Psychemedics
N/AN/AN/AN/A1 Years
United Treatment Centers Inc. stock logo
POTN
United Treatment Centers
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biocept, Inc. stock logo
BIOC
Biocept
2.88
1.81
1.70
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
0.20
4.23
4.23
Psychemedics Corporation stock logo
PMD
Psychemedics
0.01
1.82
1.82
United Treatment Centers Inc. stock logo
POTN
United Treatment Centers
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Biocept, Inc. stock logo
BIOC
Biocept
N/A
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
N/A
Psychemedics Corporation stock logo
PMD
Psychemedics
32.07%
United Treatment Centers Inc. stock logo
POTN
United Treatment Centers
N/A

Insider Ownership

CompanyInsider Ownership
Biocept, Inc. stock logo
BIOC
Biocept
1.61%
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
1.10%
Psychemedics Corporation stock logo
PMD
Psychemedics
13.96%
United Treatment Centers Inc. stock logo
POTN
United Treatment Centers
0.22%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biocept, Inc. stock logo
BIOC
Biocept
502.63 million2.58 millionNot Optionable
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
453.91 millionN/ANot Optionable
Psychemedics Corporation stock logo
PMD
Psychemedics
1406.11 million5.26 millionNot Optionable
United Treatment Centers Inc. stock logo
POTN
United Treatment Centers
13N/AN/ANot Optionable

Recent News About These Companies

Nordstrom Gets the Diamond-Hands Treatment
Biocept stock logo

Biocept NASDAQ:BIOC

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, radiation oncologists, urologists, pulmonologists, pathologists, and other physicians; and clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California. On October 13, 2023, Biocept, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Miragen Therapeutics stock logo

Miragen Therapeutics NASDAQ:MGEN

Miragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high-unmet medical need. Its four lead product candidates include cobomarsen, an inhibitor of miR-155 for treating various blood cancers, such as cutaneous T-cell lymphoma, adult T-cell lymphoma/leukemia, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia; Remlarsen, a replacement for miR-29, a microRNA that is found at abnormally low levels in various pathological fibrotic conditions, including cutaneous and ocular fibrosis, which is in Phase II clinical trial; MRG-229, which is in preclinical trial for the treatment of idiopathic pulmonary fibrosis; and MRG- 110, an inhibitor of miR-92, a microRNA expressed in endothelial cells, which has completed two Phase I clinical trial for the treatment of heart failure, wound healing, and other ischemic disease in the United States and Japan. Miragen Therapeutics, Inc. was founded in 2006 and is based in Boulder, Colorado.

Psychemedics stock logo

Psychemedics NASDAQ:PMD

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas.

United Treatment Centers stock logo

United Treatment Centers OTCMKTS:POTN

Diamond Wellness Holdings Inc., through its subsidiaries, engages in the development and sale of hemp-derived cannabidiol (CBD) oil products. It offers flavored and unflavored oils; vaping pens and additives; edibles, such as chewable gummies and lollipops; capsules; beverage energy/relaxation shots; topical application creams in various concentrations; dog and cat wellness products in various dosages and delivery formats; skin care, bath, and body products; and hemp flowers. The company provides its products under various brands, including Diamond CBD, Chill, Relax, MediPets, and Meds BioTech, as well as various other brands. It sells its products through distributors and resellers, as well as through its Website. The company was formerly known as PotNetwork Holdings, Inc. Diamond Wellness Holdings Inc. is based in Fort Lauderdale, Florida.